Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Financials
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 3 186 2313 105 3953 161 4213 698 231--
Entreprise Value (EV)1 2 875 1572 777 5452 829 7333 268 2563 037 3413 012 780
P/E ratio 14,4x16,0x26,2x17,5x15,4x13,0x
Yield 2,29%-2,47%2,46%2,77%3,23%
Capitalization / Revenue 2,44x2,39x2,53x2,80x2,66x2,46x
EV / Revenue 2,20x2,14x2,26x2,47x2,18x2,01x
EV / EBITDA 9,35x8,95x13,6x9,59x8,08x7,15x
Price to Book 2,49x2,41x2,28x2,46x2,32x2,10x
Nbr of stocks (in thousands) 1 921 1521 858 4051 857 4741 857 474--
Reference price (JPY) 1 6591 6711 7021 9911 9911 991
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 306 3481 300 8431 249 5281 322 8581 391 5561 500 393
EBITDA1 307 370310 387208 703340 640375 971421 169
Operating profit (EBIT)1 243 912243 991136 051264 307298 208344 893
Operating Margin 18,7%18,8%10,9%20,0%21,4%23,0%
Pre-Tax Profit (EBT)1 248 967245 350145 324263 569299 708342 979
Net income1 222 265195 411120 589208 575237 090269 981
Net margin 17,0%15,0%9,65%15,8%17,0%18,0%
EPS2 11510464,9114130153
Dividend per Share2 38,0-42,049,055,164,3
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1
Net sales1 615 480325 427308 621317 450326 067651 050
EBITDA ------
Operating profit (EBIT)1 86 87272 598-23 41962 62568 000135 900
Operating Margin 14,1%22,3%-7,59%19,7%20,9%20,9%
Pre-Tax Profit (EBT)1 89 09175 136-18 90366 20072 200143 200
Net income1 72 83860 079-12 32852 25056 300113 700
Net margin 11,8%18,5%-3,99%16,5%17,3%17,5%
EPS2 39,232,4-6,6326,829,961,4
Dividend per Share ------
Announcement Date 10/30/202001/29/202104/27/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 311 074327 850331 688429 975660 889685 451
Leverage (Debt / EBITDA) -1,01x-1,06x-1,59x-1,26x-1,76x-1,63x
Free Cash Flow1 233 440-167 795275 459251 339242 674257 254
ROE (Net Profit / Equities) 17,6%15,3%9,00%14,9%16,3%17,5%
Shareholders' equity1 1 262 8691 277 1961 339 8781 399 3231 452 3351 539 980
ROA (Net Profit / Asset) 13,3%11,6%6,33%10,1%10,9%11,8%
Assets1 1 676 5161 678 8581 905 1212 072 0062 170 5192 292 828
Book Value Per Share2 667694748811858947
Cash Flow per Share2 148140104156157170
Capex1 25 19041 26731 38444 57345 51150 847
Capex / Sales 1,93%3,17%2,51%3,37%3,27%3,39%
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 3 698 230 550 828
Capitalization (USD) 33 381 147 334
Net sales (JPY) 1 249 528 000 000
Net sales (USD) 11 288 235 952
Number of employees 15 455
Sales / Employee (JPY) 80 849 434
Sales / Employee (USD) 730 394
Free-Float 99,0%
Free-Float capitalization (JPY) 3 659 528 432 523
Free-Float capitalization (USD) 33 031 812 403
Avg. Exchange 20 sessions (JPY) 9 685 893 860
Avg. Exchange 20 sessions (USD) 87 502 365
Average Daily Capital Traded 0,3%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA